Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-028 (RM1 Clinical Trial Optional) RM1 Clinical Trial Optional 06/10/2025 Rachel Altshuler, Ph.D.
HEAL Initiative: Studies to Enable Analgesic Discovery RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed) R61, R33 Clinical Trial Not Allowed 01/16/2027 Rachel Altshuler, Ph.D.
HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices RFA-EB-22-002 (R18 Clinical Trial Not Allowed) R18 Clinical Trial Not Allowed 06/18/2025 Rachel Altshuler, Ph.D.
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions RFA-NS-24-021 (R01 - Clinical Trial Optional) R01 Clinical Trial Optional 02/07/2025 Rachel Altshuler, Ph.D.
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity PAR-22-092 (R01 - Clinical Trials Optional) R01 09/08/2024 Ellen Richmond, M.S., G.N.P.-B.C.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes PAR-22-131 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2025 Richard Mazurchuk, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-24-008 (R61 Clinical Trial Not Allowed) R61 Clinical Trial Not Allowed 10/02/2024 Guillermo Marquez, Ph.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-21-331 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2024 Edward Sauter, M.D., Ph.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-21-332 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 09/08/2024 Edward Sauter, M.D., Ph.D.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-23-279 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2027 Edward Sauter, M.D., Ph.D.